Literature DB >> 26614395

Symmorphosis and skeletal muscle V̇O2 max : in vivo and in vitro measures reveal differing constraints in the exercise-trained and untrained human.

Jayson R Gifford1,2, Ryan S Garten1,3, Ashley D Nelson1,3, Joel D Trinity1,3, Gwenael Layec1,3, Melissa A H Witman1,3, Joshua C Weavil1,2, Tyler Mangum1,2, Corey Hart1,2, Cory Etheredge1,2, Jake Jessop4, Amber Bledsoe4, David E Morgan4, D Walter Wray1,2,3, Matthew J Rossman2, Russell S Richardson1,2,3.   

Abstract

The concept of symmorphosis postulates a matching of structural capacity to functional demand within a defined physiological system, regardless of endurance exercise training status. Whether this concept applies to oxygen (O2 ) supply and demand during maximal skeletal muscle O2 consumption (V̇O2 max ) in humans is unclear. Therefore, in vitro skeletal muscle mitochondrial V̇O2 max (MitoO2 max , mitochondrial respiration of fibres biopsied from vastus lateralis) was compared with in vivo skeletal muscle V̇O2 max during single leg knee extensor exercise (KE V̇O2 max , direct Fick by femoral arterial and venous blood samples and Doppler ultrasound blood flow measurements) and whole-body V̇O2 max during cycling (Body V̇O2 max , indirect calorimetry) in 10 endurance exercise-trained and 10 untrained young males. In untrained subjects, during KE exercise, maximal O2 supply (KE Q̇O2max ) exceeded (462 ± 37 ml kg(-1) min(-1) , P < 0.05) and KE V̇O2 max matched (340 ± 22 ml kg(-1) min(-1) , P > 0.05) MitoO2 max (364 ± 16 ml kg(-1) min(-1) ). Conversely, in trained subjects, both KE Q̇O2max (557 ± 35 ml kg(-1) min(-1) ) and KE V̇O2 max (458 ± 24 ml kg(-1) min(-1) ) fell far short of MitoO2 max (743 ± 35 ml kg(-1) min(-1) , P < 0.05). Although MitoO2 max was related to KE V̇O2 max (r = 0.69, P < 0.05) and Body V̇O2 max (r = 0.91, P < 0.05) in untrained subjects, these variables were entirely unrelated in trained subjects. Therefore, in untrained subjects, V̇O2 max is limited by mitochondrial O2 demand, with evidence of adequate O2 supply, whereas, in trained subjects, an exercise training-induced mitochondrial reserve results in skeletal muscle V̇O2 max being markedly limited by O2 supply. Taken together, these in vivo and in vitro measures reveal clearly differing limitations and excesses at V̇O2 max in untrained and trained humans and challenge the concept of symmorphosis as it applies to O2 supply and demand in humans.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Year:  2016        PMID: 26614395      PMCID: PMC4799962          DOI: 10.1113/JP271229

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  41 in total

1.  Muscle temperature transients before, during, and after exercise measured using an intramuscular multisensor probe.

Authors:  G P Kenny; F D Reardon; W Zaleski; M L Reardon; F Haman; M B Ducharme
Journal:  J Appl Physiol (1985)       Date:  2003-02-21

2.  The concept of symmorphosis: a testable hypothesis of structure-function relationship.

Authors:  E R Weibel; C R Taylor; H Hoppeler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

3.  Aerobic metabolism of human quadriceps muscle: in vivo data parallel measurements on isolated mitochondria.

Authors:  U F Rasmussen; H N Rasmussen; P Krustrup; B Quistorff; B Saltin; J Bangsbo
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-02       Impact factor: 4.310

4.  Effect of training on enzyme activity and fiber composition of human skeletal muscle.

Authors:  P D Gollnick; R B Armstrong; B Saltin; C W Saubert; W L Sembrowich; R E Shepherd
Journal:  J Appl Physiol       Date:  1973-01       Impact factor: 3.531

Review 5.  Adaptations of skeletal muscle to endurance exercise and their metabolic consequences.

Authors:  J O Holloszy; E F Coyle
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-04

6.  A bioenergetic profile of non-transformed fibroblasts uncovers a link between death-resistance and enhanced spare respiratory capacity.

Authors:  Kristen P Nickens; Jakob D Wikstrom; Orian S Shirihai; Steven R Patierno; Susan Ceryak
Journal:  Mitochondrion       Date:  2013-09-27       Impact factor: 4.160

7.  Human muscle blood flow and metabolism studied in the isolated quadriceps muscles.

Authors:  R S Richardson; B Saltin
Journal:  Med Sci Sports Exerc       Date:  1998-01       Impact factor: 5.411

8.  Muscle mitochondrial capacity exceeds maximal oxygen delivery in humans.

Authors:  Robert Boushel; Erich Gnaiger; Jose A L Calbet; Jose Gonzalez-Alonso; Cynthia Wright-Paradis; Hans Sondergaard; Ignacio Ara; Jørn W Helge; Bengt Saltin
Journal:  Mitochondrion       Date:  2010-12-13       Impact factor: 4.160

9.  Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation.

Authors:  Brian E Sansbury; Steven P Jones; Daniel W Riggs; Victor M Darley-Usmar; Bradford G Hill
Journal:  Chem Biol Interact       Date:  2010-12-11       Impact factor: 5.192

Review 10.  Quantification of skeletal muscle mitochondrial function by 31P magnetic resonance spectroscopy techniques: a quantitative review.

Authors:  G J Kemp; R E Ahmad; K Nicolay; J J Prompers
Journal:  Acta Physiol (Oxf)       Date:  2014-05-29       Impact factor: 6.311

View more
  31 in total

Review 1.  Physiological comparison of hemorrhagic shock and V˙ O2max: A conceptual framework for defining the limitation of oxygen delivery.

Authors:  Victor A Convertino; Kristen R Lye; Natalie J Koons; Michael J Joyner
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-01

2.  Limit to steady-state aerobic power of skeletal muscles.

Authors:  A Paglietti
Journal:  J Biol Phys       Date:  2018-10-02       Impact factor: 1.365

3.  Skeletal muscle energetics are compromised only during high-intensity contractions in the Goto-Kakizaki rat model of type 2 diabetes.

Authors:  Matthew T Lewis; Jonathan D Kasper; Jason N Bazil; Jefferson C Frisbee; Robert W Wiseman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-06-12       Impact factor: 3.619

Review 4.  Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms.

Authors:  Frank W Booth; Christian K Roberts; John P Thyfault; Gregory N Ruegsegger; Ryan G Toedebusch
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 5.  Lifelong Endurance Exercise as a Countermeasure Against Age-Related [Formula: see text] Decline: Physiological Overview and Insights from Masters Athletes.

Authors:  Pedro L Valenzuela; Nicola A Maffiuletti; Michael J Joyner; Alejandro Lucia; Romuald Lepers
Journal:  Sports Med       Date:  2020-04       Impact factor: 11.136

6.  Determinants of the diminished exercise capacity in patients with chronic obstructive pulmonary disease: looking beyond the lungs.

Authors:  Ryan M Broxterman; Jan Hoff; Peter D Wagner; Russell S Richardson
Journal:  J Physiol       Date:  2020-01-19       Impact factor: 5.182

Review 7.  Novel approaches to metabolic assessment and structured exercise to promote recovery in ICU survivors.

Authors:  Jeroen Molinger; Amy M Pastva; John Whittle; Paul E Wischmeyer
Journal:  Curr Opin Crit Care       Date:  2020-08       Impact factor: 3.687

8.  NIRS-derived skeletal muscle oxidative capacity is correlated with aerobic fitness and independent of sex.

Authors:  Austin T Beever; Thomas R Tripp; Jenny Zhang; Martin J MacInnis
Journal:  J Appl Physiol (1985)       Date:  2020-07-23

9.  Maximal strength training-induced improvements in forearm work efficiency are associated with reduced blood flow.

Authors:  Ole Kristian Berg; Stian Kwak Nyberg; Tobias Midtvedt Windedal; Eivind Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-29       Impact factor: 4.733

10.  Altered skeletal muscle mitochondrial phenotype in COPD: disease vs. disuse.

Authors:  Jayson R Gifford; Joel D Trinity; Oh-Sung Kwon; Gwenael Layec; Ryan S Garten; Song-Young Park; Ashley D Nelson; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2017-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.